12 Publikationen

Alle markieren

  • [12]
    2021 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2946327 OA
    Anselmi, M., et al., 2021. Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates. Chemistry - A European Journal , 27(3), p 1015-1022.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [11]
    2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2940382 OA
    Borbély, A.N., et al., 2020. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates. Chemistry - A European Journal, 26(12), p 2602-2605.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [10]
    2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2936495 OA
    Borbély, A.N., et al., 2019. Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery. ChemistryOpen, 8(6), p 737-742.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [9]
    2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934762 OA
    Borbély, A.N., et al., 2019. Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery. Pharmaceutics, 11(4): 151.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [8]
    2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2935650 OA
    Figueras Agustí, E., et al., 2019. Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics, 11(5): 220.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [7]
    2019 | Bielefelder E-Dissertation | PUB-ID: 2934464 OA
    Figueras Agustí, E., 2019. Novel cryptophycin analogues and conjugates for tumor targeted therapy , Bielefeld: Universität Bielefeld.
    PUB | PDF | DOI
     
  • [6]
    2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2920953
    Figueras Agustí, E., et al., 2018. Novel unit B cryptophycin analogues as payloads for targeted therapy. Beilstein Journal of Organic Chemistry, 14, p 1281-1286.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [5]
    2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2932984 OA
    Cazzamalli, S., et al., 2018. In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. ACS Omega, 3(11), p 14726-14731.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [4]
    2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2944897
    Cazzamalli, S., et al., 2018. Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega, 3(12), p 16743-16743.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [3]
    2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931993
    Borbély, A.N., et al., 2018. Novel Cryptophycin-based Conjugates for Tumor Targeting. In JOURNAL OF PEPTIDE SCIENCE. no.24 Hoboken: Wiley, pp. S59.
    PUB | WoS
     
  • [2]
    2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931996
    Figueras Agustí, E., et al., 2018. Tumor Targeting of Cryptophycin based Conjugates Using Octreotide as Delivery Vehicle. In JOURNAL OF PEPTIDE SCIENCE. no.24 Hoboken: Wiley, pp. S166.
    PUB | WoS
     
  • [1]
    2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2916981 OA
    Weiss, C., et al., 2017. Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting. Journal of Peptide Science, 23(7-8), p 514-531.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     

Suche

Publikationen filtern

Darstellung / Sortierung

Export / Einbettung